Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Increased Mortality in Patients with Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation

Meng Wang, MD PhD, Wenjia Wang, PhD, Ayesha Abeywardane, MD, Malinthi Adikarama, MD, Donal McLornan, MD PhD FRCPath, Kavita Raj, MD PhD FRCPath, Hugues de Lavallade, MD PhD, Stephen Devereux, MD PhD FRCPath, Ghulam J. Mufti, DM, FRCP, FRCPath, Antonio Pagliuca, MD FRCP, FRCPath, Victoria T Potter, MD FRCPA, FRACP, Aleksandar Mijovic

Blood (2014) 124 (21): 2512.

https://doi.org/10.1182/blood.V124.21.2512.2512

Published: 2014

Journal Articles

King’s College Hospital FCC Conditioning for Severe Aplastic Anemia Induces Tolerance with Mixed T-Cell Chimerism and Extremely Low Incidence of Gvhd

Francesco Grimaldi, MD, Linda D Barber, PhD, Pilar Perez-Abellan, MSc, Rosemary Grain, Victoria T Potter, MD FRCPA, FRACP, Austin Kulasekararaj, Donal McLornan, MD PhD FRCPath, Kavita Raj, MD PhD FRCPath, Hugues de Lavallade, MD PhD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J. Mufti, MD PhD, Judith C Marsh, MD

Blood (2014) 124 (21): 1594.

https://doi.org/10.1182/blood.V124.21.1594.1594

Published: 2014

Journal Articles

Busulfan-Dose Escalation in Reduced Intensity Stem Cell Transplantation (RIC-HSCT) Results in Good Outcomes for Patients with MDS and AML without Increased Toxicity

Anita Sarma, MBChB, BSc, MRCP, Victoria T Potter, MD FRCPA, FRACP, Jennifer Clay, BM BS, FRACP, FRCPA, Donal McLornan, MD PhD FRCPath, Hugues de Lavallade, MD PhD, Kavita Raj, Judith C. W. Marsh, Austin Kulasekararaj, Antonio Pagliuca, MD FRCP, FRCPath, Ghulam Mufti, MD DM, FRCP, FRCPath

Blood (2014) 124 (21): 1236.

https://doi.org/10.1182/blood.V124.21.1236.1236

Published: 2014

Journal Articles

Hypoplastic MDS Is a Distinct Clinico-Pathological Entity with Somatic Mutations Frequent in Patients with Prior Aplastic Anaemia with Favorable Clinical Outcome

Alesia Abigael Hunt, MBChB, Anjum Bashir Khan, MBChB, MRCP, Victoria T Potter, MD FRCPA, FRACP, Donal McLornan, MD PhD FRCPath, Kavita Raj, MDPhD, Hugues de Lavallade, MD MSc, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Alexander E Smith, PhD, Judith C Marsh, MD, Austin Kulasekararaj, Ghulam J Mufti, FRCP, FRCPath

Blood (2014) 124 (21): 3269.

https://doi.org/10.1182/blood.V124.21.3269.3269

Published: 2014

Journal Articles

JAK Inhibitors Are Not Associated With a Reduction In Novel Markers Of Thrombosis In Myeloproliferative Neoplasms

Clodagh Keohane, MD, Sophia Katiri, Christopher Connor, Katy Sanchez, Roxanne Godfrey, Deepti H Radia, MD FRCPath MSc Med Ed, Donal McLornan, MD, PhD, Claire N Harrison, DM, FRCP, FRCPath

Blood (2013) 122 (21): 4091.

https://doi.org/10.1182/blood.V122.21.4091.4091

Published: 2013

Journal Articles

JAK Inhibition Reduces CD25 high CD27 + FOXp3 + T Regulatory Cells and Causes a Silencing Of T Effector Cells In Patients With Myeloproliferative Neoplasms Whilst Promoting a TH17 Phenotype

Clodagh Keohane, MD, Shahram Y Kordasti, MD, PhD, Thomas Seidl, Pilar Perez Abellan, Nicholas Shaun B. Thomas, PhD, Ghulam J Mufti, FRCP, FRCPath, Claire N Harrison, DM, FRCP, FRCPath, Donal McLornan, MD, PhD

Blood (2013) 122 (21): 4092.

https://doi.org/10.1182/blood.V122.21.4092.4092

Published: 2013

Journal Articles

BK Virus (BKV) Associated Haemorrhagic Cystitis Is Associated with Graft Versus Host Disease (GVHD) and Significant Morbidity Post Haematopoietic Stem Cell Transplant (HSCT).

Alesia Abigael Hunt, MBChB MRCP, Anjum Bashir Khan, MBChB, MRCP, Donal McLornan, MD, PhD, Majid A Kazmi, BmedBiol MB ChB MRCP(UK) MRCPath, Matthew Streetly, BMBS, MRCP, MRCPath, Victor Noriega, MD, Eithne MacMahon, Kavita Raj, MD, PhD, MRCP, FRCPath

Blood (2012) 120 (21): 3040.

https://doi.org/10.1182/blood.V120.21.3040.3040

Published: 2012

Journal Articles

Allogeneic Stem Cell Transplantation for Accelerated/Blastic Phase Philadelphia-Chromosome Negative MPN

Anjum Bashir Khan, MBChB, MRCP, Donal McLornan, MD, PhD, Yogesh Jethava, MB, MRCP, MD, FRCPath, Kavita Raj, MD, PhD, MRCP, FRCPath, Victoria T Potter, MBBS, FRCPA, FRACP, Hugues de Lavallade, MD, Majid A Kazmi, BmedBiol MB ChB MRCP (UK) MRCPath, ZiYi Lim, MD, Judith C. W. Marsh, Prof MD PhD, Sangeeta Atwal, MBBS MRCP FRCPath, Victor Noriega, MD, Claire N Harrison, DM FRCP FRCPath, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J. Mufti, MD

Blood (2012) 120 (21): 4532.

https://doi.org/10.1182/blood.V120.21.4532.4532

Published: 2012

Journal Articles

HCT-CI Is Not a Useful Predictor for Non Relapse Mortality in Older Patients (>60 years old) Receiving RIC Transplant for AML or MDS

Victor Noriega, MD, Hugues de Lavallade, MD, Victoria T Potter, MBBS, FRCPA, FRACP, Pramila Krishnamurthy, Judith C. W. Marsh, Prof MD PhD, Stephen Devereux, FRCP, FRCPath, Ph.D., Robert E. Marcus, MBBS, FRCP, FRCPath, Kavita Raj, Donal McLornan, MD, PhD, Anjum Bashir Khan, MBChB, MRCP, Sangeeta Atwal, MBBS MRCP FRCPath, Robin M. Ireland, FRCP, FRCPath, Deborah Yallop, BSc, FRCPath, MB, BS, MRCP, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J Mufti, FRCP, FRCPath, M.D.

Blood (2012) 120 (21): 4158.

https://doi.org/10.1182/blood.V120.21.4158.4158

Published: 2012

Journal Articles

Demethylating Agents As a Salvage Treatment in Relapsed Myeloid Diseases Following Allogeneic Bone Marrow Transplantation

Sangeeta Atwal, MBBS, MRCP, FRCPath, Anjum Bashir Khan, MBChB, MRCP, Victor Noriega, MD, Yogesh Jethava, MB, MRCP, MD, FRCPath, Michelle Kenyon, BSc, RN, Hugues de Lavallade, MD, Donal McLornan, MD, PhD, Victoria T Potter, MBBS, FRCPA, FRACP, Kavita Raj, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J. Mufti, MD

Blood (2012) 120 (21): 4216.

https://doi.org/10.1182/blood.V120.21.4216.4216

Published: 2012

Journal Articles

Response to Tyrosine Kinase Inhibitor Therapy In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Phase Chronic Myeloid Leukemia

Ailsa Holroyd, MD, Elizabeth Phillips, MD, Richard Szydlo, PhD, David Marin, MD, PhD, Letizia Foroni, MD, PhD, Jamshid Khorashad, MD, PhD, Dragana Milojkovic, MD, PhD, Edward J. Kanfer, MD, Francesco Dazzi, Donald H. MacDonald, MD, PhD, Amin Rahemtulla, MBBS, PhD, FRCP, Donal McLornan, MD, PhD, Ian H Gabriel, MD, Jiri Pavlu, MD, Jeremy Sargent, MD, John M. Goldman, MD, PhD, Jane F. Apperley, MD, Katayoun Rezvani, MD, PhD

Blood (2010) 116 (21): 3515.

https://doi.org/10.1182/blood.V116.21.3515.3515

Published: 2010

NARROW

Increased Mortality in Patients with Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation

King’s College Hospital FCC Conditioning for Severe Aplastic Anemia Induces Tolerance with Mixed T-Cell Chimerism and Extremely Low Incidence of Gvhd

Busulfan-Dose Escalation in Reduced Intensity Stem Cell Transplantation (RIC-HSCT) Results in Good Outcomes for Patients with MDS and AML without Increased Toxicity

Hypoplastic MDS Is a Distinct Clinico-Pathological Entity with Somatic Mutations Frequent in Patients with Prior Aplastic Anaemia with Favorable Clinical Outcome

JAK Inhibitors Are Not Associated With a Reduction In Novel Markers Of Thrombosis In Myeloproliferative Neoplasms

JAK Inhibition Reduces CD25 high CD27 + FOXp3 + T Regulatory Cells and Causes a Silencing Of T Effector Cells In Patients With Myeloproliferative Neoplasms Whilst Promoting a TH17 Phenotype

BK Virus (BKV) Associated Haemorrhagic Cystitis Is Associated with Graft Versus Host Disease (GVHD) and Significant Morbidity Post Haematopoietic Stem Cell Transplant (HSCT).

Allogeneic Stem Cell Transplantation for Accelerated/Blastic Phase Philadelphia-Chromosome Negative MPN

HCT-CI Is Not a Useful Predictor for Non Relapse Mortality in Older Patients (>60 years old) Receiving RIC Transplant for AML or MDS

Demethylating Agents As a Salvage Treatment in Relapsed Myeloid Diseases Following Allogeneic Bone Marrow Transplantation

Response to Tyrosine Kinase Inhibitor Therapy In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Phase Chronic Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only